Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy

Immunotherapy includes immune checkpoint inhibitors (ICI) such as antibodies targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or the programmed cell death protein/programmed death ligand 1 (PD-1/PD-L1) axis. Experimental and clinical evidence show that immunotherapy based on immune che...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Alice Benoit, Guillaume Vogin, Caroline Duhem, Guy Berchem, Bassam Janji
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2023-07-01
主題:	immunotherapy immune checkpoint inhibitors tumor microenvironment metabolic reprogramming hypoxia
オンライン･アクセス:	https://www.mdpi.com/2073-4409/12/13/1787